GSK-J4 combined with mitomycin C as a novel combination therapy for non-muscle invasive bladder cancer

Frontiers in Oncology ◽

10.3389/conf.fonc.2019.01.00010 ◽

2019 ◽

Vol 9 ◽

Author(s):

Anna-Maria Caridis ◽

Callum Perkins ◽

Alessandro Di Maio ◽

Douglas Ward ◽

Udo Oppermann ◽

...

Keyword(s):

Bladder Cancer ◽

Combination Therapy ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Comparison of the combination therapy of bacillus Calmette-Guérin and mitomycin C with the monotherapy for non-muscle-invasive bladder cancer: a meta-analysis

Neoplasma ◽

10.4149/neo_2016_616 ◽

2016 ◽

Vol 63 (06) ◽

pp. 967-976 ◽

Author(s):

Y. LAN ◽

D. LIU ◽

M. LIN

Keyword(s):

Bladder Cancer ◽

Combination Therapy ◽

Mitomycin C ◽

Meta Analysis ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Targeting of BRD4 with JQ1, combined with mitomycin C as a novel combination therapy for non-muscle invasive bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(18)31300-9 ◽

2018 ◽

Vol 17 (2) ◽

pp. e663 ◽

Author(s):

C. Simm ◽

A. Caridis ◽

A. Di Maio ◽

P. Knowles ◽

B. Gorman ◽

...

Keyword(s):

Bladder Cancer ◽

Combination Therapy ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study

Case Medical Research ◽

10.31525/ct1-nct03844256 ◽

2000 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Curative Treatment ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Bladder Sparing

Download Full-text

Re: Intravesical Gemcitabine in Combination with Mitomycin C as Salvage Treatment in Recurrent Non-Muscle-Invasive Bladder Cancer

The Journal of Urology ◽

10.1016/j.juro.2017.01.008 ◽

2017 ◽

Vol 197 (4) ◽

pp. 1005-1005

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Salvage Treatment ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C

BMC Urology ◽

10.1186/s12894-018-0408-6 ◽

2018 ◽

Vol 18 (1) ◽

Author(s):

Andrew T. Lenis ◽

Kian Asanad ◽

Maher Blaibel ◽

Nicholas M. Donin ◽

Karim Chamie

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Transurethral Resection ◽

Invasive Bladder Cancer ◽

Bladder Tumors ◽

Muscle Invasive Bladder Cancer ◽

Bladder Irrigation ◽

Muscle Invasive

Download Full-text

Prospective randomized clinical trial of chemohyperthermia with mitomycin-C prior to transurethral resection of the bladder and its relationship with the rate of early recurrence in non-muscle invasive bladder cancer: Intermediate analysis

European Urology Open Science ◽

10.1016/s2666-1683(20)33373-5 ◽

2020 ◽

Vol 19 ◽

pp. e1175-e1176

Author(s):

C. Garcia Alvarez ◽

A.C. Plata Bello ◽

J. Plata Bello ◽

M.A. Tamayo Jover ◽

T. Concepción Masip

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Mitomycin C ◽

Transurethral Resection ◽

Early Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Prospective Randomized Clinical Trial ◽

Muscle Invasive

Download Full-text

Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracil

Radiotherapy and Oncology ◽

10.1016/j.radonc.2020.07.057 ◽

2020 ◽

Vol 150 ◽

pp. 275-280 ◽

Author(s):

Charlotte S. Voskuilen ◽

Maaike W. van de Kamp ◽

Nannet Schuring ◽

Laura S. Mertens ◽

Arjen Noordzij ◽

...

Keyword(s):

Bladder Cancer ◽

Single Dose ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

1669 INTRAVESICAL ADJUVANT ELECTROMOTIVE MITOMYCIN-C IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER A RANDOMIZED CONTROLLED TRIAL

The Journal of Urology ◽

10.1016/j.juro.2012.02.1527 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Savino Mauro Di Stasi ◽

Cristian Verri ◽

Emanuele Liberati ◽

Francesco Micali ◽

Francesco Masedu ◽

...

Keyword(s):

Bladder Cancer ◽

Randomized Controlled Trial ◽

Mitomycin C ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Intermediate Risk ◽

Muscle Invasive Bladder Cancer ◽

Randomized Controlled ◽

Muscle Invasive

Download Full-text

Cystectomy outcomes in patients who have failed Radiofrequency-induced Thermo-chemotherapeutic Effect Mitomycin-C (RITE-MMC) treatment for high-risk non-muscle invasive bladder cancer (HRNMIBC)–Does it complicate surgery and adversely impact oncological outcome?

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.09.016 ◽

2020 ◽

Author(s):

Denosshan Sri ◽

Hack Jae Lee ◽

Sarah El-Gemmal ◽

Chris Backhouse ◽

Andrea Tay ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Oncological Outcome ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Chemotherapeutic Effect ◽

Muscle Invasive

Download Full-text

PD19-07 ONE-YEAR FOLLOW-UP RESULTS AFTER SEQUENTIAL INTRAVESICAL BACILLUS CALMETTE-GUÉRIN AND DEVICE-ASSISTED CHEMO-HYPERTHERMIA (MITOMYCIN C DELIVERED BY THE COMBAT BRS SYSTEM) FOR HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS...A BACILLUS CALMETTE-GUÉRIN-SPARING STRATEGY

The Journal of Urology ◽

10.1016/j.juro.2017.02.880 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

TR Leyshon Griffiths ◽

William JF Green ◽

Peter T Grice ◽

Jonathan C Goddard ◽

Roger C Kockelbergh

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Download Full-text